Comparison of kidney and hepatic outcomes among sodium-glucose cotransporter-2 inhibitors: a retrospective study using multiple propensity scores
Renoprotective and hepatoprotective effects are class effects of SGLT2i, and their effects are thought to be independent of kidney or liver status.
Authors
- Chiho Kurumazuka
- Haruka Goto (ORCID: https://orcid.org/0000-0003-2213-5830)
- Yūki Yamashita (ORCID: https://orcid.org/0000-0002-0162-4208)
- Akio Shibanami
- Akihiko Takagi (ORCID: https://orcid.org/0000-0002-1357-7437)
- Chinami Suzuki
- Kazuya Hiura (ORCID: https://orcid.org/0009-0008-3133-2784)
- Kiyomi Ishida
- Yuki Tanaka
- Ryu Kobayashi (ORCID: https://orcid.org/0000-0003-1075-2372)
- Akifumi Mizutani
- Shigo Takatori
- Junichi Kubo
Institutions
- Hokkaido University of Science (JP)
- Otaru Municipal Hospital (JP)
- Obihiro Kosei General Hospital (JP)
- Sapporo Kosei General Hospital (JP)
- Asahikawa Kosei Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1186/s40780-024-00378-2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00